蕈样肉芽肿免疫标志物及相关药物治疗进展

Progress in Immune Markers and Relevant Drug Therapies of Mycosis Fungoides

摘要: 蕈样肉芽肿(mycosis fungoides，MF)是一种原发性皮肤T细胞淋巴瘤，既往研究证实其发病与免疫学异常密切相关。近年来，治疗MF的新药陆续出现，尤其是分子靶向药物，其作用机制与相应的免疫标志物相关。本文就MF免疫标志物及其相关药物治疗进展进行综述。

Abstract: Mycosis fungoides (MF) is a primary cutaneous T-cell lymphoma. The pathogenesis is closely associated with immunological abnormalities. Some novel drugs have emerged recently, especially molecular targeted drugs, which are related to the immune markers of MF. Here we summarized the progress of its immune markers and related drug therapies.